Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cytophage Technologies Ltd
V.CYTO
Alternate Symbol(s):
CPTCF
Healthcare
Biotechnology
Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals...
, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CYTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on Apr 30, 2024 10:45am
New and growing
Construction started on its new 20,000 sq ft facility that will include a state-of-the-art laboratory, GMP-certified manufacturing suite, administrative offices and warehouse space. It is
...more
(33)
•••
Speedmaster2022
X
Comment by
Speedmaster2022
on Apr 30, 2024 10:43am
RE:RE:Expecting news re
Cytophage entered into a Distribution Agreement with Renata Limited-Animal Health Division in Dhaka, Bangladesh (“Renata”) for the distribution of Cytophage’s animal health products by Renata in
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 30, 2024 7:30am
New Press Release - Cytophage Announces Fiscal Year End 2023 Results
(TheNewswire)Winnipeg, April 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, today released its fiscal year end results for the year ending...
read article.
(2120)
•••
lscfa
X
Comment by
lscfa
on Apr 29, 2024 10:12am
RE:First Quarterly Statements
Annual audited fins due today. Q1 fins due end of May.
(999)
•••
a2bman
X
Comment by
a2bman
on Apr 29, 2024 8:15am
RE:First Quarterly Statements
I think the year end for both the takeover target and cyto is dec 31. They have 120 days post year end and 60 post quarter so we should have something before the end of the month. Do they
...more
(0)
•••
cklv0
X
Post by
cklv0
on Apr 25, 2024 4:08pm
First Quarterly Statements
Given the company went public arounf 2/10/24, I am thinking first look at the qtr stmts would be around 5/15 to 6/15 dependent on canadian rules which I am not familiar with. Only SEC.
(33)
•••
Speedmaster2022
X
Comment by
Speedmaster2022
on Apr 25, 2024 12:19pm
RE:RE:Expecting news re
Good question...I doubt there were testing issues as the pages are customized. Perhaps the focus has shifted to domestic markets?
(0)
•••
cklv0
X
Comment by
cklv0
on Apr 24, 2024 3:52pm
RE:Expecting news re
There has been no updates on the Asian business which started last year? Wonder if there was a problem with the testing?
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on Apr 24, 2024 3:44pm
Bids/asks exaggerated
Pretty hefty L2 pissing contest for a new, low float stock. think I'll stick around to watch.
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on Apr 23, 2024 1:59pm
Expecting news re
An application for regulatory approval in the United States has been submitted and a similar regulatory approval submission for Canada is currently being developed. Upon completion of field
...more
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on Apr 23, 2024 1:57pm
Unexpected turn of events
Expanding prospects and national visibility apparently leads to new lows. Arghh...
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on Apr 18, 2024 9:16am
Ready to rock
Thanks for your patience. I have enough now. Shall we drive off these lows? Please and thank you
(2120)
•••
lscfa
X
Post by
lscfa
on Apr 02, 2024 9:16am
Update on Bacteriophage Human Trial at The Ottawa Hospital
https://www.thenewswire.com/press-releases/1Bz4F9aq9-cytophage-provides-update-on-bacteriophage-human-trial-at-the-ottawa-hospital.html
(2120)
•••
lscfa
X
Post by
lscfa
on Mar 26, 2024 7:58pm
Ottawa Hospital first in Canada to try new therapy for chron
https://ottawa.ctvnews.ca/ottawa-hospital-first-in-canada-to-try-new-therapy-for-chronic-artificial-joint-infection-1.6819558
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*